Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

August 6, 2011

UK’s NHS, NOT playing Nice to Multiple Sclerosis Drug Fingolimod (Gilenya)

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Article Date: 05 Aug 2011 In a draft decision, Britain’s independent body that recommends whether drugs should be covered by…
MS Drug Therapies

August 5, 2011

The triggers for Multiple Sclerosis – Interview with Professor Anne-Louise Ponsonby, Head Environmental and Genetic Epidemiology Research Group

  • Multiple Sclerosis
    /
=========================================================== Remain CURRENT with Multiple Sclerosis news  and information,  when registered at our  MS Views and News website . .Providing You with ‘MS Views and News’, is what we do  . On the 4th Wednesday…
Multiple Sclerosis

August 3, 2011

FDA Okays New Label Claim for Fingolimod (Gilenya)

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
By John Gever, Senior Editor, MedPage Today Published: August 02, 2011 The oral multiple sclerosis drug fingolimod (Gilenya) reduces T1 gadolinium-enhancing…
MS Drug Therapies

August 3, 2011

Leave the Door Open – A story from an MS Patient

  • An MS Patients Story
    /
A story to me means a plot where there is some surprise. Because that is how life is – full…
An MS Patients Story

August 2, 2011

Actelion drug cuts brain lesions in MS patients

  • MS Research Study and Reports
    /
August 2, 2011 – ZURICH (Reuters) – Actelion’s experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the…
MS Research Study and Reports

August 1, 2011

Teva’s Laquinimod fails to reduce MS relapse

  • MS Drug Therapies
    /
  • Oral MS Medications
    /
Teva’s Copaxone Successor Fails in Latest Clinical Trial By Naomi Kresge Aug. 1 (Bloomberg) — Teva Pharmaceutical Industries Ltd.’s experimental…
MS Drug Therapies

August 1, 2011

Israel’s Weizmann Institute of Science leads in research and discovery

  • Misc. Research Reports
    /
  • MS Research Study and Reports
    /
  • Stem Cell Related
    /
Washington, July 29, 2011-At the dawn of life, as babies are born, they enter a welcoming world filled with surprises…
Misc. Research Reports

July 31, 2011

Unusual Weather and Your Multiple Sclerosis

  • Ask an MS Nurse
    /
By Cherie C. Binns RN BS MSCN – July 2011 The summer of 2011 has shown us many unusual weather…
Ask an MS Nurse

July 31, 2011

Free Wireless and Discounted Land Line Phone Service for Qualified Consumers

  • For the Benefit of the Patient
    /
  • News from the MS Foundation
    /
News from the MS Foundation: If the cost of phone service is keeping you disconnected, you may be able to…
For the Benefit of the Patient

July 31, 2011

A Study of Ocrelizumab in People with Primary Progressive MS

  • MS Pain and Side Effects
    /
  • MS Research Study and Reports
    /
..This randomized, parallel group, double-blind, placebo controlled study will evaluate the efficacy and safety of ocrelizumab in people with primary-progressive…
MS Pain and Side Effects

Categories

Latest Blog Posts